JE
CVS icon

JMAC Enterprises’s CVS Health CVS Stock Holding History

JMAC Enterprises’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,544
Closed -$362K – 175
2024
Q1 		$362K Sell
4,544
-503
-10% -$38.4K 0.07% 136
2023
Q4 		$399K Sell
5,047
-3,800
-43% -$270K 0.09% 129
2023
Q3 		$618K Sell
8,847
-981
-10% -$69.5K 0.15% 111
2023
Q2 		$679K Buy
9,828
+1,470
+18% +$105K 0.17% 103
2023
Q1 		$621K Buy
8,358
+3,031
+57% +$254K 0.16% 106
2022
Q4 		$496K Buy
5,327
+1,479
+38% +$143K 0.14% 119
2022
Q3 		$367K Buy
+3,848
New +$381K 0.1% 137

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JMAC Enterprises's CVS Position: Q2 2024 in Review

JMAC Enterprises sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,544 shares — an estimated $362K sold.

JMAC Enterprises first reported a position in CVS in Q3 2022 and held it in 7 quarters. The position peaked at $679K in Q2 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • JMAC Enterprises reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • JMAC Enterprises sold 4,544 CVS Health shares in Q2 2024, an estimated $362K.
  • JMAC Enterprises first reported a position in CVS Health in Q3 2022 and held it in 7 quarters.
  • JMAC Enterprises's CVS Health position peaked at $679K in Q2 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on JMAC Enterprises's 13F filing for Q2 2024, filed 30 Jul 2024.